Literature DB >> 20383874

The efficacy of n-acetylcysteine in preventing contrast-induced nephropathy in type 2 diabetic patients without nephropathy.

Fuat Sar1, Tayyibe Saler, Alphan Ecebay, Zuhal A Saglam, Savas Ozturk, Rumeyza Kazancioglu.   

Abstract

BACKGROUND: N-acetylcysteine (NAC) is reported to have potential for prevention of contrast-induced nephropathy(CIN), however, there is not enough data related to its effects on diabetic patients without nephropathy.
METHODS: A total of 45 diabetic patients without nephropathy undergoing a computerized tomography (CT) investigation and who would be receiving radio-opaque medication (300 mg iohexaol/100 mL) were enrolled. They were randomized to have either high-dose NAC (1200 mg) plus saline hydration (Group 1, n=25) or only saline hydration (Group 2; n=20). Serum creatinine levels were determined 72 hours post-contrast. CIN was defined as 0.3 mg/dL elevation of creatinine from baseline and/or an increment of 20% over baseline creatinine and/or 20% decrement of estimated GFR.
RESULTS: In Group 1, serum creatinine decreased from 0.83 to 0.79 mg/dL, whereas serum creatinine increased from 0.81 to 0.94 mg/dL in Group 2 (not significant for both groups). However there was a significant difference between the creatinine variation of two groups (p=0.031). Furthermore, the groups were analyzed according to overall incidence of CIN. The increase of serum creatinine and decrement of estimated GFR in Group 2 were significantly higher than in Group 1.
CONCLUSION: Adding NAC to saline hydration seems more beneficial than saline hydration alone in preventing contrast-induced renal function deterioration in type 2 diabetic patients without nephropathy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20383874

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  6 in total

1.  Prevention and management of contrast-induced acute kidney injury.

Authors:  Patricia J M Best; David R Holmes
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-02

2.  N-acetylcysteine in handgrip exercise: plasma thiols and adverse reactions.

Authors:  Leonardo F Ferreira; Kenneth S Campbell; Michael B Reid
Journal:  Int J Sport Nutr Exerc Metab       Date:  2011-04       Impact factor: 4.599

3.  Sesame oil prevents acute kidney injury induced by the synergistic action of aminoglycoside and iodinated contrast in rats.

Authors:  Dur-Zong Hsu; Ya-Hui Li; Pei-Yi Chu; Srinivasan Periasamy; Ming-Yie Liu
Journal:  Antimicrob Agents Chemother       Date:  2011-03-14       Impact factor: 5.191

Review 4.  The effectiveness of N-Acetylcysteine in preventing contrast-induced nephropathy in patients undergoing contrast-enhanced computed tomography: a meta-analysis of randomized controlled trials.

Authors:  Mei-Yi Wu; Hui-Fen Hsiang; Chung-Shun Wong; Min-Szu Yao; Yun-Wen Li; Chao-Ying Hsiang; Chyi-Huey Bai; Yung-Ho Hsu; Yuh-Feng Lin; Ka-Wai Tam
Journal:  Int Urol Nephrol       Date:  2013-01-03       Impact factor: 2.370

Review 5.  Prevention of contrast-induced AKI: a review of published trials and the design of the prevention of serious adverse events following angiography (PRESERVE) trial.

Authors:  Steven D Weisbord; Martin Gallagher; James Kaufman; Alan Cass; Chirag R Parikh; Glenn M Chertow; Kendrick A Shunk; Peter A McCullough; Michael J Fine; Maria K Mor; Robert A Lew; Grant D Huang; Todd A Conner; Mary T Brophy; Joanne Lee; Susan Soliva; Paul M Palevsky
Journal:  Clin J Am Soc Nephrol       Date:  2013-05-09       Impact factor: 8.237

6.  Effectiveness of contrast-associated acute kidney injury prevention methods; a systematic review and network meta-analysis.

Authors:  Khalid Ahmed; Terri McVeigh; Raminta Cerneviciute; Sara Mohamed; Mohammad Tubassam; Mohammad Karim; Stewart Walsh
Journal:  BMC Nephrol       Date:  2018-11-13       Impact factor: 2.388

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.